Spruce Biosciences Stock Performance
| SPRB Stock | USD 0.55 0.02 3.77% |
On a scale of 0 to 100, Spruce Biosciences holds a performance score of 6. The entity has a beta of 0.9, which indicates possible diversification benefits within a given portfolio. Spruce Biosciences returns are very sensitive to returns on the market. As the market goes up or down, Spruce Biosciences is expected to follow. Please check Spruce Biosciences' value at risk and the relationship between the expected short fall and price action indicator , to make a quick decision on whether Spruce Biosciences' existing price patterns will revert.
Risk-Adjusted Performance
6 of 100
Weak | Strong |
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Spruce Biosciences are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Spruce Biosciences sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
1 | The Schall Law Firm Is Inquiring Into Whether Spruce Biosciences, Inc. Committed Securities Fraud And Stockholders Are Urged To Reach Out | 09/12/2024 |
2 | Spruce Biosciences, Inc. Is Being Investigated For Possible Securities Fraud And Affected Shareholders Are Urged To Contact The Schall Law Firm | 09/30/2024 |
3 | The Schall Law Firm Is Inquiring Into Spruce Biosciences Inc For Securities Law Violations And Investors With Losses Should Reach Out | 10/03/2024 |
4 | Investors Are Encouraged To Join The Schall Law Firms Inquiry Into Spruce Biosciences Inc For Securities Law Violations | 10/11/2024 |
5 | Spruce Biosciences, Inc. Is Being Investigated For Securities Fraud And The Schall Law Firm Urges Affected Shareholders To Reach Out | 10/24/2024 |
6 | Spruce Biosciences Releases Quarterly Earnings Results, Beats Estimates By 0.06 EPS | 11/13/2024 |
7 | ARMISTICE CAPITAL, LLC Acquires New Stake in Spruce Biosciences Inc | 11/15/2024 |
8 | Disposition of 842020 shares by Novo Holdings As of Spruce Biosciences at 0.7684 subject to Rule 16b-3 | 11/22/2024 |
| Begin Period Cash Flow | 24.7 M |
Spruce |
Spruce Biosciences Relative Risk vs. Return Landscape
If you would invest 46.00 in Spruce Biosciences on August 29, 2024 and sell it today you would earn a total of 7.00 from holding Spruce Biosciences or generate 15.22% return on investment over 90 days. Spruce Biosciences is currently generating 0.2727% in daily expected returns and assumes 3.2482% risk (volatility on return distribution) over the 90 days horizon. In different words, 28% of stocks are less volatile than Spruce, and 95% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Spruce Biosciences Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Spruce Biosciences' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Spruce Biosciences, and traders can use it to determine the average amount a Spruce Biosciences' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.084
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | SPRB | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.25 actual daily | 28 72% of assets are more volatile |
Expected Return
| 0.27 actual daily | 5 95% of assets have higher returns |
Risk-Adjusted Return
| 0.08 actual daily | 6 94% of assets perform better |
Based on monthly moving average Spruce Biosciences is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Spruce Biosciences by adding it to a well-diversified portfolio.
Spruce Biosciences Fundamentals Growth
Spruce Stock prices reflect investors' perceptions of the future prospects and financial health of Spruce Biosciences, and Spruce Biosciences fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Spruce Stock performance.
| Return On Equity | -0.58 | ||||
| Return On Asset | -0.3 | ||||
| Operating Margin | (15.63) % | ||||
| Current Valuation | (34.94 M) | ||||
| Shares Outstanding | 41.3 M | ||||
| Price To Book | 0.42 X | ||||
| Price To Sales | 3.08 X | ||||
| Revenue | 10.09 M | ||||
| EBITDA | (47.37 M) | ||||
| Net Income | (47.92 M) | ||||
| Cash And Equivalents | 93.3 M | ||||
| Cash Per Share | 3.96 X | ||||
| Total Debt | 4.61 M | ||||
| Debt To Equity | 0.07 % | ||||
| Current Ratio | 9.55 X | ||||
| Book Value Per Share | 1.25 X | ||||
| Cash Flow From Operations | (33.27 M) | ||||
| Earnings Per Share | (0.95) X | ||||
| Market Capitalization | 21.88 M | ||||
| Total Asset | 103.95 M | ||||
| Retained Earnings | (197.23 M) | ||||
| Working Capital | 77.72 M | ||||
About Spruce Biosciences Performance
By analyzing Spruce Biosciences' fundamental ratios, stakeholders can gain valuable insights into Spruce Biosciences' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Spruce Biosciences has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Spruce Biosciences has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.46) | (0.48) | |
| Return On Capital Employed | (0.65) | (0.69) | |
| Return On Assets | (0.46) | (0.48) | |
| Return On Equity | (0.63) | (0.60) |
Things to note about Spruce Biosciences performance evaluation
Checking the ongoing alerts about Spruce Biosciences for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Spruce Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Spruce Biosciences has some characteristics of a very speculative penny stock | |
| Spruce Biosciences had very high historical volatility over the last 90 days | |
| Spruce Biosciences has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 10.09 M. Net Loss for the year was (47.92 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Spruce Biosciences currently holds about 93.3 M in cash with (33.27 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.96, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Spruce Biosciences has a frail financial position based on the latest SEC disclosures | |
| Latest headline from gurufocus.com: ARMISTICE CAPITAL, LLC Acquires New Stake in Spruce Biosciences Inc |
- Analyzing Spruce Biosciences' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Spruce Biosciences' stock is overvalued or undervalued compared to its peers.
- Examining Spruce Biosciences' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Spruce Biosciences' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Spruce Biosciences' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Spruce Biosciences' stock. These opinions can provide insight into Spruce Biosciences' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Spruce Stock analysis
When running Spruce Biosciences' price analysis, check to measure Spruce Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Spruce Biosciences is operating at the current time. Most of Spruce Biosciences' value examination focuses on studying past and present price action to predict the probability of Spruce Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Spruce Biosciences' price. Additionally, you may evaluate how the addition of Spruce Biosciences to your portfolios can decrease your overall portfolio volatility.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |